(Q84982048)
Statements
Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy (English)
Akira Goto
Yasutaka Sukawa
Hisayoshi Igarashi
Kei Onodera
Yuka Aoki
Kazuya Suzuki
Kazuhiko Yonezawa
Atsushi Yawata
Toshihisa Kobayashi
Hiroyuki Kaneto
Haruo Shimizu
Hideki Wakasugi
Yasutaka Matsunaga
Miki Itoh
Hiroyuki Okuda
Yoshiaki Arimura
Yasuhisa Shinomura
1 September 2011